Wired

Trump’s FDA Cuts Are Putting Drug Development at Risk

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.

Mar 4, 2025 - 02:00
Trump’s FDA Cuts Are Putting Drug Development at Risk
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.
Read More

Tags:

Previous Article

Millwall deplore Roberts abuse after Mateta incident

Next Article

Elon Musk’s $1 Spending Limit Is Paralyzing Federal Agencies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Chinese Companies Rush to Put DeepSeek in Everything

Chinese Companies Rush to Put DeepSeek in Everything

Mar 12, 2025

China Is Investigating Google Over Trump’s Tariffs

China Is Investigating Google Over Trump’s Tariffs

Feb 5, 2025

Google Has Unleashed Its Legal Fury on Hackers and Scammers

Google Has Unleashed Its Legal Fury on Hackers and Scam...

Aug 15, 2024